FHL3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-26395
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Predicted:
Bovine (100%), Porcine (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence DQVLCQGCSQAGP corresponding to C-Terminus according to NP_004459.2.
Epitope
C Terminus
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for FHL3 Antibody
Western Blot: FHL3 Antibody [NBP1-26395]
Western Blot: FHL3 Antibody [NBP1-26395] - (1ug/ml) Western blot analysis of Human Skeletal Muscle lysate (35ug protein in RIPA buffer) using NBP1-26395 at 1ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.Applications for FHL3 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:4000
Western Blot
1 - 3 ug/ml
Application Notes
WB: Approx. 30 kDa band observed in human, mouse and rat skeletal muscle lysates (calculated MW of 31.2 kDa band according to NP_004459.2).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: FHL3
Alternate Names
FHL-3, four and a half LIM domains 3, four and a half LIM domains protein 3, LIM-only protein FHL3, MGC19547, MGC8696, Skeletal muscle LIM-protein 2, SLIM-2, SLIM2MGC23614
Entrez Gene IDs
2275 (Human)
Gene Symbol
FHL3
UniProt
Additional FHL3 Products
Product Documents for FHL3 Antibody
Product Specific Notices for FHL3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...